Zhejiang, China

Zhao Sun

This inventor holds 2 USPTO granted patents. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhao Sun. Retrieved from https://idiyas.com/inventor/zhao-sun-0jrx3xe8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Zhao Sun

Introduction

Zhao Sun is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that address immune-related disorders. With a total of 2 patents, Zhao Sun is recognized for his innovative approaches to medical challenges.

Latest Patents

One of Zhao Sun's latest patents is a PD-L1 antagonist compound. This patent includes a compound of Formula (I) and a pharmaceutical composition thereof. It also outlines a method for using the compounds of Formula (I) to prevent and/or treat immune-related disorders. This innovation showcases his commitment to advancing healthcare solutions.

Career Highlights

Zhao Sun is currently employed at Adlai Nortye Biopharma Co., Ltd., where he continues to push the boundaries of biopharmaceutical research. His work at this company has positioned him as a key player in the industry, contributing to the development of novel therapies.

Collaborations

Zhao Sun collaborates with talented individuals such as Zhiyong Yu and Pan Li. These partnerships enhance the innovative capacity of his projects and contribute to the overall success of their research endeavors.

Conclusion

Zhao Sun's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treating immune-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…